Hyperbaric oxygen therapy in primary headache: A research review

Biomedical Research

Volumn 16, Issue 3, 2005, Pages 143-160

  Nwosu, Ijoma A ^a   Khan, Abrar A ^a  

^a University of Sint Eustatius School of Medicine   (Netherlands)

Author keywords

Aura; BBB; Cluster headache; HBOT; Hyperbaric oxygen; Migraine headache; Tension headache

Indexed keywords

ADENOSINE; CALCITONIN GENE RELATED PEPTIDE; DOPAMINE; EXCITATORY AMINO ACID; MAGNESIUM; NEUROTRANSMITTER; NITRIC OXIDE; ORAL CONTRACEPTIVE AGENT; OXYGEN; SEROTONIN;

BRAIN MITOCHONDRION; CLUSTER HEADACHE; DOPPLER ECHOGRAPHY; ESTRADIOL BLOOD LEVEL; EVOKED VISUAL RESPONSE; HEADACHE; HUMAN; HYPERBARIC OXYGEN; INTERNATIONAL CLASSIFICATION OF DISEASES; MAGNESIUM DEFICIENCY; MENOPAUSAL SYNDROME; MIGRAINE; MIGRAINE WITH AURA; MITOCHONDRIAL ENERGY TRANSFER; NEUROIMAGING; NEUROTRANSMITTER RELEASE; OXIDATIVE STRESS; OXYGEN THERAPY; PATHOPHYSIOLOGY; PREMENSTRUAL SYNDROME; REVIEW; SEROTONIN RELEASE; SPREADING CORTICAL DEPRESSION; TENSION HEADACHE; THROMBOCYTE AGGREGATION; TRIGEMINAL NERVE; UPREGULATION;

EID: 29644447716     PISSN: 0970938X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (178)

1. Gonzales R. Common symptoms. In: Current medical diagnosis and treatment. 44 th edition. Lange medical books McGraw-Hill, New York 2005: pp31-33.
2. Raskin NH. In: Harrison's Principles of Internal Medicine. Volume1 13 th Edition. McGraw-Hill, New York 1994; p 66.
3. Leao AA. Spreading depression of Activity in Cerebral Cortex. J Neurophysiol 1944; 7: 359-390.
4. Silberstein S.D. Practice Parameter: evidence-based guidelines for migraine headache; report of the Quantity Standards Subcommittee of American Academy of Neurology. Neurology 2000; 26: 55: 754-762.
5. Fields HL, Martin JB: Cardinal Manifestations of disease: in Harrison's Principles of Internal Medicine 13 th Ed Vol. 1. New York, McGraw-Hill. 1994; 49.
6. Headache classifications Committee of HIS: Cephalalgia 1988;8 Suppl 7:1-96.
7. Cephalalgia. Vol 24 Suppliment 1, 2004.
8. Bookspan J, Fife CE, Fife WP: Hyperbaric oxygen therapy in headache. In: Textbook of Hyperbaric Medicine. 3 rd Ed. Hogrefe & Huber 1999, Seattle: pp393-402.
9. Counihan TJ: Headache, neck pain and other painful disorders. In: Cecil Essentials of Medicine. 6 th Edition. W.B. Saunders Co, Philadelphia 2004: pp 998-999.
10. Lipton RB, Stewart WR and Simon D. American Migraine study. Headache 1998; 38: 87-96.
11. Krymchantowski AV, Bigal ME, Moreira PF. New and emerging prophylactic agents for migraine. CNS Drugs 2002; 16: 611-634.
12. Thomas E, Boardman H, Ogden H, Millson D, Croft P. Classification of headache disorders II. Cephalgia 2004; 24 supplement 1.
13. Devinsky O, Feldmann E, Weinreb HJ, Wilterdink JL. The resident's neurology book. Philadelphia, Davis, 1997; 39-50.
14. April L, Carson AP, Rose KM, Sanford CP, Ephross SA, Stang PE, Hunt KJ, Brown CA, Szklo M. Lifetime Prevalence of Migraine And Other Headaches lasting 4 or more hours: The Atherosclerosis Risk In Communities (ARIC) Study. Headache: the Journal of Head and face Pain 2004; 44: 20-28.
15. Jensen R. Pathophysiological mechanisms of tension-type headache: a review of epidemiological and experimental studies. Cephalalgia 1999; 19: 602-621.
16. May A, Evers S, Straube A, Pfeffenrath V, Diener HC. Treatment and prophylaxis for cluster headaches and other trigeminal autonomic headaches. Revised recommendations of the German Migraine and Headache Society. Schmerz. 2005; 19: 225-241.
17. Welch. KMA, Dannley D, Simkins TR. The role of Estrogen in Migraine: A review and hypothesis. Cephalalgia 1984; 4: 159.
18. Granella F, Cavallini A, Sandrini G, Manzoni GC, Nappi G. Long- term outcome of migraine. Review. Cphalalgia. 1998; 21: 30-33.
19. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of Migraine in the United States. JAMA 1992; 67: 64-69.
20. Zhao F, Tsay JY, Cheng X. Epidemiology of migraine, a survey in 21 provinces of the People's Republic of China 1985. Headache 1988; 28: 558-565.
21. Aukerman G, Knutson D, Miser WF. Management of Acute Migraine Headache. Review. Am Fam Physician 2002; 66: 2123-2130
22. Pryse-Phillips W, Findlay H, Tugwell P, Edmeads J, Murray TJ, Nelson RF. A Canadian population survey on the clinical, epidemologic and societal impact of migraine and tension-type headache. Can J Neurol Sci 1992; 19: 333-339.
23. Oshuntokun BO, Oshuntokun O. Complicated migraine and hemoglobin S in Nigerians. Br Med J 1972; 2: 621-622.
24. Oshuntokun O, Oshuntokun BO. Ophthalmoplegic migraine and hemoglobinopathy in Nigerians. Am J Ophthalmology 1972; 74: 451-455.
25. Teckle HR, Seraw B, Forsgren L, Ekbom K Ekstedt J. Migraine, CTTH and cluster headache in an Ethiopian rural community. Cephalalgia. 1995; 15: 449-450.
26. Roh JK, Kim JS, Ahn YO: Epidemiologic and clinical characteristics of migraine and tension-type headache in Korea. Headache 1992; 38: 356-365.
27. Cheung RT. Prevalence of migraine, tension-type headache and other headaches in Hong Kong. Headache 2000; 4: 473-479.
28. Koseoglu E, Nacar M, Talaclioglu A, Cetinkaya F. Epidemiological and clinical characteristics of migraine and tension-type headache in 114 females in Kayseri, Turkey. Cephalagia 2003; 23: 381-388.
29. Cady RK. Diagnosis and Treatment of migraine: Review. Clin Conerstone 1999; 1: 21-32.
30. Hu XH, Markson LE, Lipton RB, Stewart WF, Berger ML. Burden of migraine in the United States: disability and economic costs. Arch Intern Med 1999; 159: 813-818.
31. van Suijlekom HA, Lame I, Stomp-van den Berg SG, Kessels AG, Weber WE. Quality of life of patients with cervicogenic headache: a comparison with control subjects and patients with migraine or tension-type headache. Headache 2003; 43: 1034-1041.
32. Williamson DJ, Hargreaves RJ. Neurogenic inflammation in the context of migraine. Microsc Res Tech 2001; 53: 167-178.
33. Olesen J. Cerebral and extracranial circulatory disturbances in migraine:pathophysiological Implications. Cerebrovasc Brain Metab Rev 1991; 3: 1-28.
34. Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine - studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 1993; 33: 48-56.
35. NINCIS.nil.gov: Migraine pathophysiology. Headache: The Journal of Head and Face Pain. 43(9), 1019-101.
36. Srikiatkhachorn A, Maneesri S, Govitrapong P, Kasanticul V. Derangement of serotonin 1998;38(1):43-49.
37. Fabricius M, Akgoren N, Lauritzen M. Arginine-nitric oxide pathway and cerebrovascular regulation in cortical spreading depression. Am J Phisiol 1995; 269: H23-29
38. Thomsen LL. Investigation into the role of nitric oxide and the large intracranial arteries in migraine headache. Cephalalgia 1997; 17: 873-895.
39. Thomsen L L, Olesen J. Nitric oxide theory of migraine. Clin Neurosci 1998; 5: 28-33. Review.
40. Lassen LH, Ashina M, Christiansen L, Ulrich V, Grover R, Donaldson J, Olesen J. Nitric oxide synthase inhibition: a new principle in the treatment of migraine attacks. Cephalalgia 1998; 18: 27-32.
41. Christiansen I, Thomsen LL, Daugaard D, Ulrich V, Olesen J. Glyceryl trinitrate induces attacks of migraine without aura in sufferers of migraine with aura. Cephalalgia 1999; 19: 660-667; Discussion 626.
42. Guieu R, Devaux C, Henry H, Bechis G, Pouget J, Mallet D, Sampieri F, Juin M, Gola R, Rochat H. Adenosine and migraine. Can J Neurol Sci 1998; 25: 55-58.
43. Okada H, Araga S, Takeshima T, Nakashima K. Plasma lactic acid and pyruvic acid levels in migraine and tension-type headache. Headache 1998; 31: 39-42.
44. Schoenen J. Cortical electrophysiology in migraine and possible pathogenic implications. Clin Neurosci 1998; 5: 10-17.
45. Opavsky J. Magnesium and its combination with cinnarizine in the long-term treatment of headache. Acta Univ Palacki Olumuc Fac Med 1991; 131: 157-164.
46. Mauskop A, Altura BT, Cracco RQ, Altura BM. Intravenous magnesium sulfate relieves cluster headaches in patients with low serum ionized magnesium levels. Headache 1995; 35: 597-600.
47. Mauskop A, Altura BT, Cracco RO, Altura BM. Intravenous magnesium sulfate rapidly alleviates headaches of various types. Headache 1996 Mar; 36:154-160.
48. Cete Y, Dora B, Ertan C, Ozdemir C, Oktay C. A randomized prospective placebo-controlled study of intravenous magnesium sulfate vs metochlopramide in the management of acute migraine attacks in the Emergency Department. Cephalalgia 2005; 25: 199-204.
49. Jenkins DW, Feniuk W, Humphrey PP. Characterization of the prostanoid receptor types involved in mediating calcitonin gene-related peptide release from cultured rat trigeminal neurons. Br J Pharmacol 2001; 134: 1296-1302.
50. Jenkins DW, Langmead CJ, Parsons AA, Strijbos PJ. Regulation of calcitonin gene-related peptide release from rat trigeminal nucleus caudalis slices in vitro. Neurosci Lett 2004; 366: 241-244.
51. Edvinson L. Both neurogenic and vascular causes of primary headache. Lakartidningen 2001; 98: 4176-4183.
52. Edvinson L. Aspects of the pathophysiology of migraine and cluster headache. Pharmacol Toxicol 2001; 89: 65-73.
53. Limmroth V, Katsarava Z, Liedert B, Guehring H, Schmitz K, Diener HC, Michel MC. An in vivo rat model to study calcitonin gene-related peptide release following activation of the trigeminal vascular system. Pain 2001; 92: 101-106.
54. Lassen LH, Haderslev PA, Jacobsen VB, Iversen HK, Sperling B, Olesen J. CGRP may play a causative role in migraine. Cephalalgia 2002; 22: 54-61.
55. Moreno MJ, Abounader R, Hebert E, Doods H, Hamel E. Efficacy of the non-peptide CGRP receptor antagonist BIBN4096BS in blocking CGRP-induced dilatations in human and bovine cerebral arteries: potential implications in acute migraine treatment. Neuropharmacology 2002; 42: 68-76.
56. Strecker T, Dux M, Messlinger K. Nitric oxide releases calcitonin gene-related peptide from rat dura mater encephali promoting increases in meningeal blood flow. J Vasc Res 2002; 39: 489-496.
57. Pardutz A, Multon S, Malgrange B, Parduez A, Vecsei L, Schoenen J W. Effects of systemic nitroglycerine on CGRP and 5-HT afferents to rat caudal spinal trigeminal nucleus and its modulation of estrogen. Eur J Neurosci 2002; 15: 1803-1809.
58. MaQ P, Hill R, Sirinathsinghji D. Colocalization of CGRP with 5-HT1B/1D receptors and substance P in trigeminal ganglion neurons in rats. Eur J Neurosci 2001; 13: 2099-2104.
59. Arulmani U, Maassenvandenbrink A, Villanon CM, Sexena PR. Calcitonin gene-related peptide and its role in migraine pathophysiology. Eur. J. Pharmacol. 2004; 500: 315-330.
60. Juhasz G, Zsombok T, Modos EA, OIG. NO-induced migraine attack: strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release. Pain 2003; 106: 461-470.
61. Storer RJ, Akerman S, Goadsby PJ. Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat. Br J Pharmacol 2004; 142: 1171-1181.
62. Sarchielli P, Alberti A, Vaianella L, Pierguidi L, Floridi A, Mazzotta G, Floridi A, Gallai V. Chemokine levels in jugular venous blood of migraine without aura patients during attacks. Headache 2004; 44: 961-968.
63. Durham PL, Cady R, Cady R. Regulation of Calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin Type A: implications for migraine therapy. Headache 2004; 44: 35-42.
64. Silberstein SD. Menstrual migraine. J Womens Health Gend Based Med 1999; 8: 919-931.
65. Sommerville BW. The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology 1972; 22: 355-365.
66. Sommerville BW. Estrogen withdrawal migraine I. Neurology 1975; 25: 239-244.
67. Benedetto C, Allais G, Ciochetto D, De Lorenzo C: Pathophysiological aspects of menstrual migraine. Caphalalgia 1997; 20: 32-34 Review.
68. Cupini LM. Sex-Hormone Related Events in Migrainous Females. Cephalalgia 1996; 15: 140-144.
69. Silberstein S. AASH Proceedings, November 1997, p 96.
70. Moore KL, Persaud TVN. Before We Are Born. Essentials of Embryology & Birth Defects. 6 th Ed. China Saunders 2003.
71. Recober A, Geweke LO. Menstrual migraine. Curr Neurol Neurosci Rep 2005; 5: 93-98. Review.
72. Watters WE, O'Connor PJ. Epidemiology of headache and migraine in women. Journal of Neurology, Neurosurgery & Psychiatry 1971; 34: 148.
73. Kudrow L. The Relationship of Headache Frequency to Hormone Use in Migraine. Headache 1975; 15: 36-40.
74. Neri I, Granella F, Nappi R, Manzoni GF, Facchinetti F, Genazzani AR. Characteristics of Headache at Menopause:a clinico- epidemiologic Study. 1993; 17: 31-37.
75. Tzourio C. Case-control study of migraine and risk of ischemic stroke in young women. British Medical Journal 1995; 310: 830-833.
76. Sommerville BW. Estrogen Withdrawal Migraine II. Attempted prophylaxis by continuous estradiol administration. Neurology 1975; 25: 239.
77. Ryan RA. Controlled study of the effect of contraceptives on migraine headache. Headache 1978; 17: 250-251.
78. Lichten EM, Bennett RS, Whitty AJ, Daoud Y. Efficacy of Danazol in the Control of Hormonal Migraine. Journal of Reproductive Medicine 1991; 36: 419-424.
79. Lichten EM, Lichten JB, Whitty AJ, Pieper D. The Use of Leuprolide Acetate in the Diagnosis and Treatment of Menstrual Migraine: The Role of artificially-induced menopause. Headache Quarterly 1995; 6: 313-317.
80. Thomas E, Boardman H, Ogden h, Millson D, Croft P. Migraine prevalence in male-to-female transsexuals on hormone therapy. Neurology 2004; 63: 593-594.
81. Hainline B. Headache. Neurologic Clinics 1994; 12: 443-460.
82. DeAngelis LM. CNS Neoplasm in Pregnancy. Raven Press 1994.
83. Khan K, Chang J. Neonatal abstinence Syndrome due to codeine. Arch Dis Child Fetal Neonatal Ed. 1997; 76: F59-60.
84. Loder L. AASH Proceedings, Scottsdale, November 1997; 145: 335-338.
85. Sicuteri F, Fanciullacci M, Geppetti P, Renzi D, Caleri D, Spillantini MG. Substance P mechanism in cluster headache; evaluation in cerebrospinal fluid. Cephalalgia. 1985; 5: 143-149.
86. Mascia A, Afra J, Schoenen J. Dopamine and migraine: a review of pharmacological, biochemical, neurophysiological and therapeutic data. Cephalalgia 2001 Jul; 21: 706-707.
87. Fanciullacci M, Alessandri M, Del Rosso A. Dopamine involvement in migraine attack. Funct Neurol 2000; 15: 171-181.
88. Bes A, Geraud G, Guell A, Arne-Bes MC. Dopaminergic hypersensitivity in migraine: A dignostic test? Nouv Presse Med 1982; 11: 1475-1478.
89. Blin O, Azulay JP, Masson G, Aubrespy G, Serratrice G. Apomorphine-induced yawning in migraine patients: enhanced responsiveness. Clin. Neuropharmacol. 1991; 14: 91-95.
90. Cerbo R, Barbanti P, Buzzi MG, Fabbrini G, Brusa L, Roberti C, Zanette E, Lenzi GL. Dopamine hypersensitivity in migraine:role of apomorphine test. Clin Neuropharmacol 1997; 20: 36-41.
91. Barbanti P, Fabbrini G, Ricci A, Pascali MP, Bronzetti E, Amenta F, Lenzi GL, Cerbo R. Migraine patients show an increased density of dopamine D3 and D4 receptors on lymphocytes. Cephalalgia. 2000; 20: 15-19.
92. Lee TJF. Identification of 5-HT receptor subtypes mediating 5-HT-induced relaxation of porcine pial veins. Biomed Res 2000; 11: 201-208.
93. Anthony M, Lance JW. Plasma serotonin in patients with chronic tension headache. J Neurol Neurosurg Psychiatry. 1989; 52: 182-184.
94. Martelletti P, Alteri E, Pesce A, Rinaldi-Garaci C, Giacovazzo M. In vitro interactions of serotonin (5-HT) with mononuclear cells from migraine patients: alterations related to the phase of attack. J Neuroimmunol 1988; 18: 17-24.
95. Giacovazzo M, Bernoni RM, Di Sabato F, Martelletti P. Impairment of 5HT binding to lymphocytes and monocytes from tension-type headache patients. Headache 1990; 30: 220-223.
96. Marazziti D, Bonuccelli U, Nuti A, Toni C, Pedri S, Palego L, Pavese N. Platelet 3H-imipramine binding and sulphotransferase activity in primary headache. Cephalagia 1994; 14: 210-214.
97. Jensen R, Hindberg I. Plasma serotonin increase during episodes of tension-type headache Cephalalgia. 1994; 14: 219-222.
98. Srikiatkhachorn A, Anthony M. Platelet serotonin in patients with analgesic-induced headache Cephalalgia. 1996; 16: 423-426.
99. Bendtsen L, Jensen R, Hindberg I, Gammeltoft S, Olesen J. Serotonin metabolism in chronic tension - type headache. Cephalalgia 1997; 17: 843-848.
100. Bendtsen, L, Mellerup ET. The platelet serotonin transporter in primary headache. Eur J Neurol 1998; 5: 277-282.
101. D'andrea G, Granella F, Alecci M, Manzoni GC. Serotonin metabolism in cluster headache. Cephalalgia 1998; 18: 94-96.
102. Shioka U, Harscher S, Diehl RR, van Schayck R, Nieaen WD, Weiller C. Spontaneous oscillations in cerebral blood flow velocity give evidence of different autonomic dysfunction in various types of headache. Headache 2001; 41: 157-163.
103. Shukla R, Husain M, Tandon R, Khanna VK, Nag D, Dikshit M, Srimal RC, Seth PK: Platelet 3H Ketanserin binding in tension-type headache. Headache 2003; 43: 103-108.
104. D'andrea G, Cananzi AR, Joseph R, Morra M, Zamberlan F, Ferro Milone F, Grunfeld S, Welch KM. Platelet glucine, glutamate and aspartate in primary headache. Cephalalgia 1991; 11: 197-200.
105. Alam Z, Coombes N, Waring RH, Williams AC, Steventon GB. Plasma levels of neuroexcitatory amino acids in patients with migraine or tension headache. J Neorol Sci 1998; 156: 102-106.
106. Ramadan NM. The link between glutamate and migraine. CNS Spectr 2003; 8: 446-449.
107. Perez MF, Zukerman, Senne Soares CA, Alonso EO, Santos BF, Faulhaber MH. Crebrospinal fluid glutamate in chronic migraine. Cephalalgia 2004; 24: 735-739.
108. Battistella P A, Bordin A, Cernetti R, Broetto S, Corra S, Piva E, Plebani M. Beta-endorphin in plasma and monocytes in juvenile headache. Headache 1996; 36: 91-94.
109. Mazzotta G, Sarchielli P, Gaggioli A, Gallai V. Study of pressure pain and cellular concentration of neurotransmitters related to nociception in episodic tension-type headache patients. Headache 1997; 37: 565-571.
110. Buzzi MG, Pellegrino MG, Bellantino P. Causes and mechanisms of primary headaches: toward a biobehavioral model. Ital J Neuro Sci. 1995; 16: 15-19.
111. Burstein R, Yamamura H, Malick A, Strassman AM. Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in the brain stem trigeminal neurons. J. Neurophysiol 1998; 79: 964-982.
112. May A, Goadsby PJ. The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation. J Cereb Blood Flow Metab 1999; 19: 115-127.
113. Edvinsson L, Uddman R. Neurobiology of primary headaches. Brain Res. Brain Res Rev 2005; 48: 438-456.
114. Blau JN. Migraine. Theories of Pathogenesis. Lancet 1992; 339: 1202.
115. Gerber WD, Schoenen J. Biobehavioral correlates in migraine: the role of hypersensitivity and information processing dysfunction. Cephalalgia 1998; 18: 5-11.
116. Nouchine H. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. PNA598: 4687-4692.
117. Aurora SK, Welch KM. Migraine: imaging the aura. Curr Opin. Neurol. 2000; 13: 273-276 Review.
118. Ebersberger A, Schaible HG, Averbeck B, Richter F: Is there a correlation between spreading depression, neurogenic inflammation and nociception that might cause migraine headache? Ann Neurol 2001; 49: 7-13.
119. Legrain V, Janne P, Laloux P, Ossemann M, Dupuis M, Reynaert C. Clinical and pathophysiological contribution of event-related potentials used to study migraine headache. Rev Neurol (Paris) 2001; 157: 365-375.
120. Tepper SJ, Rapoport A, Sheftell F. The pathophysiology of migraine. Neurology 2001; 7: 279-286.
121. Thomas E, Sandor PS, Ambrosini A, Schoenen J. A neural network model of sensitization of evoked cortical responses in migraine. Cephalalgia 2002; 22: 48-53.
122. Battelli L, Black KR, Wray SH. Transcranial Magnetic stimulation of visual area V5 in Migraine. Neurology 2002; 58: 1066-1069.
123. Ambrosini A, Schoenem. J. The electrophysiology of migraine. Curr Opin Neurol. 2003; 16: 327-332.
124. Sanchez Del Rio, Reuter U. Migraine aura; new information on underlying mechanisms. Curr.Opin.Neurol 2004; 17: 289-293.
125. Scher AI, Bigal ME, Lipton RB. Co-morbidity of migraine. Curr Opin Neurol 2005; 18: 305-310.
126. Gursvy-Ozdemir Y, Oiu J, Matsuoka N, Bolay H, Bermpohl D, Jim H, Wung X, Rosenberg GA, Lo EH, Moskowitz MA. Cortical spreading depression activates and upregulates MMP-9. J. Clin Invest 2004; 113: 1447-1455.
127. Goadsby PJ, Adner M, Edvinsson L. Characterization of endothelial receptors in the cerebral vasculature and their lack of effect on spreading depression. J. Cereb. Blood Flow Metab 1996; 16: 698-704.
128. Mitsikostas DD, Sanchez del Rio M. Receptor systems mediating C-fos expression within trigeminal nucleus caudalis in animal models of migraine. Brain Res Brain Res Rev 2001; 35: 20-35.
129. Dreier PJ, Kleeberg J, Petzold G, Priller J, Windmuller O, Orzechowski HD, Lindauer U, Heinemann U, Einhaupl KM, Dirnagl U. Endothelin-1 potently induces Leao's cortical spreading depression in vivo in the rat:a model for an endothelial trigger of migrainous aura? Brain. 2002; 125(PH): 102-112.
130. Gesztelyi G. Primary headache and depression. Orv Hetil 2004; 145: 2419-24. Review. Hungarian.
131. Radat F, Swendsen J. Psychiatric co-morbidity in migraine: a review. Cephalalgia 2005; 25: 165-178.
132. Choi YC, Kim WJ, Kim CH, Lee MS. A clinical study of chronic headaches: clinical characteristics and depressive trends in migraine and tension-type headaches. Yonsei Med J 1995; 36: 508-514.
133. Carlsson J, Larsson B, Mark A: Psychosocial functioning in school children with recurrent headaches. Headache 1996; 36: 77-82.
134. Cao M, Zhang S, Wang K, Wang Y, Wang W: Personality traits in migraine and tension-type headaches; a five-factor model study. Psychopathology 2002; 35: 254-258.
135. Anttila P, Sourander A, Metsahonkala L, Aromaa M, Helenius H, Sillanpaa M. Psychiatric symptoms in children with primary headache. J. Am. Acad. Child Adolesc. Psychiatry. 2004; 43: 412-419.
136. Shimomura T, Araga S, Kowa H, Takahashi K. Immunoglobulin kappa/lambda ratios in migraine and tension-type headaches. Jpn J Psychiatry Neurol. 1992 Sep; 46 (3): 721-726
137. Galli V, Sarchielli P, Trequattrini A, Paciaroni M. Monocyte chemotactic and phagocytic responses in migraine and tension-type headache patients. Ital J. Neurol Sci 1993; 14: 152-164.
138. Leone M, Biffi M, Leoni F, Bussone G. Leukocyte subsets and cortical serum levels in patients with migraine without aura and chronic tension-type headache. Cephalalgia. 1994; 14: 139-142.
139. Fife CE, Powell MG, Sutton TE. Transcranial doppler evaluation of middle cerebral artery from 1 ATA to 3 ATA of oxygen. Undersea and Hyperbaric Med 1994; 21: 77
140. Fife C, Powell M, Sutton TE. Transcranial Doppler Evaluation of Middle Cerebral Artery During Hyperbaric Oxygenation. Undersea and Hypebaric Med. 1993; 20: 14.
141. Sukoff MH, Ragatz R E. Hyperbaric oxygen for the treatment of acute cerebral edema. Neurosurgery 1982; 10: 29-38
142. Bergo GW, Risberg J, Tyssebotn I. Effect of 5 bar oxygen on cardiac output and organ blood flow in conscious rats. Undersea Biomed Res 1988; 15: 457-470.
143. Demchenko IT, Boso AE, Bennet PB, Whorton AR, Piantadosi CA: Hyperbaric oxygen reduces cerebral blood flow by inactivating nitric oxide. Nitric oxide 2000; 4: 596-608.
144. Zhilyaev SY, Moskvin AN, Platonova TF, Gutsaev DR, Churilina IV, Demchenko IT. Hyperoxic vasoconstriction in the brain is mediated by inactivation of nitric oxide by superoxide anions. Neurosci Behav Physiol 2003; 33: 783-787.
145. Di Sabato F, Giacavazzo M, Cristalli G. Effect of hyperbaric oxygen on the immuuno reactivity of substance P in the nasal mucosa of cluster headache patients. Headache 1996; 36: 221-223.
146. Di Sabato F, Rocco M, Martelleti P. Hyperbaric oxygen in chronic cluster headache; influence on sertonergic pathways. Undersea and Hyperbaric Medicine 1997; 24: 117-122.
147. Di Sabato F, Rocco M, Martelletti P, Giacovazzo M. Hyperbaric oxygen in chronic cluster headaches: influence on serotonergic pathways. Undersea Hyperb Med. 1997; 24: 117-22.
148. Mink RB, Ducta AJ. Hyperbaric oxygen after global cerebral ischemia in rabbits reduces brain vascular permeability and blood flow. Stroke 1995; 26: 2307-2312.
149. Liu Y, Rosenthal RE, Haywood Y, Miljkovic-Lolic M, Vanderhoek JY, Fiskum G. Normoxic Ventilation after cardiac arrest reduces oxidation of brain lipids and improves neurological outcome. Stroke 1998; 29: 1679-1686.
150. Veltkamp R, Warner DS, Domain F, Bronchus AD, Tooled JF, Bosnia DW. Hyperbaric oxygen decreases infarct size and behavioral deficit after transient focal cerebral ischemia in rats. Brain Res 2000 Jan 17; 853: 68-73.
151. Xiong L, Zhu Z, Dong H, Hu W, Hou L, Chen S. Hyperbaric oxygen preconditioning induces neuroprotection against ischemia in transient non-permanent middle cerebral artery occlusion in rat model. Chin Med J (Engl); 113: 836-839.
152. Konda A, Baba S, Iwaki T, Harai H, Koga H, Kimura T, Takamatsu J. Hyperbaric oxygen prevents neuronal death following tranasient ischemia in the gerbil hippocampus. Neuropathol Appl Neurobiol 1996; 22: 350-360.
153. Sukoff MN. Effects of hyperbaric oxygenation. J Neurosurg 2001; 94: 403-411.
154. Rockswold SB, Rockswold GL, Vargo JM, Erickson CA, Sutton RL, Bergman TA, Biros MH. Effects of hyperbaric oxygen therapy on cerebral metabolism and intracranial pressure in severely brain injured patients. J Neorosurg 2001; 95: 544-546.
155. Calvert JW, Yin W, Patel M, Badr A, Mychaskiw G, Parent AD, Zhang TH. Hyperbaric oxygenation prevents brain injury induced by hypoxia-ischemia in neonatal rat model. Brain Res. 2002; 27; 951: 1-8.
156. Miljkovic-Lolic M, Silbergleit R, Fiskum G, Rosenthal RE. Neuroprotective effect of hyperbaric oxygen treatment in experimental focal cerebral ischemia is associated with reduced brain leukocyte myeloperoxidase activity. Brain Res 2003; 971: 90-94.
157. Rosenthal RE, Silbergleit R, Hof PR, Haywood Y, Fiskum G. Hyperbaric oxygen reduces neuronal death and improves neurological outcome after canine cardiac arrest. Stroke 2003; 34: 1311-1316.
158. Schabitz WR, Schade H, Heiland S, Kollmar R, Bardutzky J, Henninger N, Muller H, Carl U, Toyokuni S, Sommer C, Schwab S. Neuroprotection by hyperbaric oxygen after experimental focal cerebral ischemia monitored by MRI. Stroke 2004; 35: 1175-1179.
159. Daugherty WP, Levasseur JE, Sun D, Rockswold GL, Bullock M. Effects of hyperbaric oxygen therapy on cerebral oxygenation and mitochondrial function following moderate lateral fluid-percussion injury in rats. J Neurosurg 2004; 101: 499-504.
160. Kruit MC, van Buchem MA, Hofman PA, Bakkers JT, Terwindt GM, Ferrari MD, Launer LJ. Migraine as a risk factor for subclinical brain lesion. JAMA 2004; 291: 427-434.
161. Lipton RB, Pan J. Is migraine a progressive brain disease? JAMA 2004; 291; 493-494.
162. Garcia-Covarrubias L, Cuauhtemoc Sanchez-Rodriguez E. Hyperbaric oxygen therapy, basic concepts. Gac Med Mex 2000; 136: 45-56. Review. Spanish.
163. Fife WP, FiFe CE. Treatment of Migraine headache with hyperbaric oxygen. J Hyperbaric medicine 1989; 4: 7-15.
164. Wilson JR, Foresman B.H. Gamber RG, Wright T. Hyperbaric oxygen in the treatment of migraine. Undersea Hyperb Med 1996; 23: 157-165.
165. Wilson JR, Foresman BH, Gamber RG, Wright T. Hyperbaric oxygen in the treatment of migraine with aura. Headache. 1998; 38: 112-115.
166. Johnson GD. Medical management of migraine-related dizziness and vertigo. Laryngoscope. 1998; 108: 1-28.
167. Heckl RW. Cluster Headache and chronic paroxysmal hemicrania- effectiveness of oxygen inhalation. Nervenarzt 1986; 57: 311-313.
168. Weiss LD, Ramasastry SS, Eidelman BH. Treatment of a cluster headache patient in a hyperbaric chamber. Headache 1989; 29: 109-110.
169. Pascual J, Peralta G, Sanchez U. Preventive effects of hyperbaric oxygen in cluster headache. Headache 1995; 35: 260-261.
170. Stovner LJ, Sjaastad O. Treatment of cluster headache and its variants. Curr Opin Neurol 1995; 8: 243-247.
171. Nilsson Remahl AI, Ansjon R, Lind F, Waldenlind E. Hyperbaric Oxygen Treatment of Active Cluster Headache: a double-blind placebo-controlled cross-over study Cephalalgia 2002; 22: 730-739.
172. D'Amico D, Grazzi L, Leone M, Moschiano F, Bussone G. A review of the treatment of primary headaches Part II: Tension-type headache. Ital J Neorol Sci. 1998; 19: 2-9.
173. Jensen R, Olesen J. Tension-type headache: an update on the mechanism and treatment. Curr Opin Neurol 2000; 13: 285-289.
174. Nelson CF. The tension headache, migraine headache continuum; a hypothesis. J Manipulative Physiol Ther 1994; 17: 156-167. Review.
175. Schade AJ. Quantitative assessment of tension-type headache and migraine severity continuum. Headache 1997 Nov-Dec; 37 (10):646-53.
176. Shevel E. Migraine/tension-type headache continuum. S Afr Med J 2000 Sep; 90: 869-871. Review
177. Centonze V, Bassi A, Casssiano MA, Munno I, Dalfino L, Causarano V. Migraine, daily chronic headache, and fibromyalgia in the same patient: an evolutive continuum of an organic chronic pain? About 100 cases. Neurol Sci 2004; 24: S291-292.
178. Myers DE, Myers RA. A preliminary report on hyperbaric oxygen in the relief of migraine headache. Headache 1995; 35: 197-199.